Diamond Hill Capital Management’s Gilead Sciences GILD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-2,728,609
| Closed | -$191M | – | 172 |
|
|
2021
Q3 | $191M | Buy |
2,728,609
+12,150
| +0.4% | +$849K | 0.72% | 54 |
|
|
2021
Q2 | $187M | Buy |
2,716,459
+89,765
| +3% | +$6.18M | 0.71% | 55 |
|
|
2021
Q1 | $170M | Buy |
2,626,694
+251,968
| +11% | +$16.3M | 0.69% | 52 |
|
|
2020
Q4 | $138M | Buy |
2,374,726
+12,041
| +0.5% | +$702K | 0.65% | 55 |
|
|
2020
Q3 | $149M | Buy |
2,362,685
+75,172
| +3% | +$4.75M | 0.82% | 46 |
|
|
2020
Q2 | $176M | Buy |
2,287,513
+221,244
| +11% | +$17M | 1.04% | 40 |
|
|
2020
Q1 | $154M | Sell |
2,066,269
-122,090
| -6% | -$9.13M | 1.05% | 41 |
|
|
2019
Q4 | $142M | Buy |
2,188,359
+122,836
| +6% | +$7.98M | 0.71% | 48 |
|
|
2019
Q3 | $131M | Buy |
2,065,523
+92,919
| +5% | +$5.89M | 0.7% | 52 |
|
|
2019
Q2 | $133M | Buy |
1,972,604
+106,895
| +6% | +$7.22M | 0.71% | 51 |
|
|
2019
Q1 | $121M | Buy |
1,865,709
+105,067
| +6% | +$6.83M | 0.67% | 55 |
|
|
2018
Q4 | $110M | Buy |
1,760,642
+7,077
| +0.4% | +$443K | 0.65% | 56 |
|
|
2018
Q3 | $135M | Buy |
1,753,565
+121,423
| +7% | +$9.38M | 0.67% | 51 |
|
|
2018
Q2 | $116M | Buy |
1,632,142
+577,590
| +55% | +$40.9M | 0.59% | 56 |
|
|
2018
Q1 | $79.5M | Buy |
1,054,552
+1,003,610
| +1,970% | +$75.7M | 0.41% | 73 |
|
|
2017
Q4 | $3.65M | Buy |
+50,942
| New | +$3.65M | 0.02% | 136 |
|
|
2016
Q1 | – | Sell |
-2,070
| Closed | -$209K | – | 167 |
|
|
2015
Q4 | $209K | Buy |
+2,070
| New | +$209K | ﹤0.01% | 164 |
|